This month we are joined by Dr Daniel Spratt, from University Hospitals Seidman Cancer Center/ Case Western Reserve University, who discusses Molecular Classifiers for Treatment Rationalisation of Localised Disease. We will also hear from Prof Bertrand Tombal, from Université catholique de Louvain, Louvain-la-Neuve, who will present on LHRH Antagonists vs Agonists. It is co-chaired by Dr Sumit Subudhi, from MD Anderson Cancer Center, who leads the group disucssion to close the episode.